Role of cell-cycle regulatory proteins in gynecological cancer

Cited in:

CrossRef

This article has been cited by:

1. 1
   Piotr K. Zakrzewski, Adam I. Cygankiewicz, Jacek Mokrosiński, Maria Nowacka-Zawisza, Andrzej Semczuk, Tomasz Rechberger, Wanda M. Krajewska, Expression of Endoglin in Primary Endometrial Cancer, Oncology, 2011, 81, 3-4, 243

   CrossRef

2. 2
   J M Cunningham, R A Vierkant, T A Sellers, C Phelan, D N Rider, M Liebow, J Schildkraut, A Berchuck, F J Couch, X Wang, B L Fridley, A Gentry-Maharaj, U Menon, E Hogdall, S Kjaer, A Whittemore, R DiCioccio, H Song, S A Gayther, S J Ramus, P D P Pharaoh, E L Goode, Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis, British Journal of Cancer, 2009, 101, 8, 1461

   CrossRef

3. 3
   Angiolo Gadducci, Stefania Cosio, Roberta Tana, Andrea Riccardo Genazzani, Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer, Critical Reviews in Oncology/Hematology, 2009, 69, 1, 12

   CrossRef

4. 4
   E.J. NAM, Y.T. KIM, Alteration of cell-cycle regulation in epithelial ovarian cancer, International Journal of Gynecological Cancer, 2008, 18, 6

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(180K)
   • References
5. 5
   Nicole Horrée, Paul J. van Diest, Daisy M.D.S. Sie-Go, A. Peter M. Heintz, The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators, Human Pathology, 2007, 38, 8, 1232

   CrossRef

6. 6
   Gian F Zannoni, Beatrice Faraglia, Elisabetta Tarquini, Andrea Camerini, Karen Vrijens, Mario Migaldi, Achille Cittadini, Alessandro Sgambato, Expression of the CDK inhibitor p27kip1 and oxidative DNA damage in non-neoplastic and neoplastic vulvar epithelial lesions, Modern Pathology, 2006, 19, 4, 504

   CrossRef

7. 7
   I A. M van der Avoort, H Shirango, B M Hoevenaars, J M. M Grefte, J A de Hullu, P C. M de Wilde, J Bulten, W J. G Melchers, L F. A. G Massuger, Vulvar Squamous Cell Carcinoma is a Multifactorial Disease Following Two Separate and Independent Pathways, International Journal of Gynecological Pathology, 2006, 25, 1, 22

   CrossRef

8. 8
   Young Tae Kim, Min Zhao, Aberrant Cell Cycle Regulation in Cervical Carcinoma, Yonsei Medical Journal, 2005, 46, 5, 597

   CrossRef

9. 9
   Kun-Tu Yeh, Ming-Yu Yang, Ta-Chih Liu, Jui-Chang Chen, Wen-Ling Chan, Sheng-Fung Lin, Jan-Gowth Chang, Abnormal expression of period 1 (PER1) in endometrial carcinoma, The Journal of Pathology, 2005, 206, 1

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(675K)
   • References
10. 10
    Ratnesh Kumar Singh, Santanu Dasgupta, Nilanjana Bhattacharya, Neelanjana Chunder, Ranjit Mondal, Anup Roy, Syamsundar Mandal, Susanta Roychowdhury, Chinmay Kumar Panda, Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma, Journal of Cancer Research and Clinical Oncology, 2005, 131, 6, 395

    CrossRef

11. 11
    Carmilia Jiménez Ramírez, Juliet M. Haberbusch, Dianne Robert Soprano, Kenneth J. Soprano, Retinoic acid induced repression of AP-1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cells, Journal of Cellular Biochemistry, 2005, 96, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(278K)
    • References
12. 12
    Andrzej Semczuk, Danuta Skomra, Katarzyna Jankiewicz, Aneta Adamiak, Elżbieta Korobowicz, Tomasz Rechberger, The immunohistochemical profile of the primary and metastatic carcinoma of the clitoris: a case report, Archives of Gynecology and Obstetrics, 2005, 273, 3, 187

    CrossRef

13. 13
    Andrzej Semczuk, Jerzy Andrzej Jakowicki, Alterations of pRb1-cyclin D1-cdk4/6-p16INK4A pathway in endometrial carcinogenesis, Cancer Letters, 2004, 203, 1, 1

    CrossRef

14. 14
    Takao Watanabe, Kayo Sumida, Tomoko Muto, Yoko Kashida, Tomoyuki Watanabe, Kunitoshi Mitsumori, Analysis of Gene Expression Profile on Uterine Tumorigenesis Initiated with N-ethyl-N-nitrosourea and Inhibited by Ethinylestradiol in rasH2 Mice, Journal of Toxicologic Pathology, 2004, 17, 3, 155

    CrossRef

15. 15
    Andrzej Semczuk, Marek Cybulski, Jacek Tomaszewski, Tomasz Rechberger, Jerzy A. Jakowicki, Clinicoprognostic significance of pRb1 pathway alterations in uterine endometrial adenocarcinoma, Cancer Genetics and Cytogenetics, 2004, 154, 2, 186

    CrossRef

16. 16
    Wei Li, Carol H Thompson, Yvonne E Cossart, Christopher J O'Brien, Jihong Liu, Richard A Scolyer, Jonathan R Carter, Christopher Dalrymple, Barbara R Rose, The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer, Modern Pathology, 2004, 17, 9, 1031

    CrossRef